Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-85.17	-988.98	6670.44
Graham Fair Price	-4.90	14.71	15.47
PEG	3436.34	-11.19	0.32
Price/Book	10.12	11.24	10.20
Price/Cash Flow	-11.57	-16.07	-14.41
Prices/Earnings	4.86	-19.29	-20.28
Price/Sales	1.66	57.25	56.32
Price/FCF	-11.57	-16.07	-14.41
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-15.96	0.11	0.13
Operating Margin	-12.62	-0.53	-0.47
ROA	2.53	-0.02	-0.02
ROE	-0.13	-0.15	-15.74
ROIC	-0.02	-0.02	-2.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.10	< 0.005	6024.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.03	-0.08	-150.91
EPS QOQ	0.64	-0.02	-97.31
FCF QOQ	-0.38	0.12	-67.68
Revenue QOQ	0.06	-0.04	-33.69
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	198.19	223.28	12.66
Days Sales Outstanding (DSO)	131.20	102.47	-21.90
Inventory Turnover	0.45	0.40	-11.24
Debt/Capitalization	0.82	0.85	3.55
Quick Ratio	4.38	3.82	-12.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	9.19	8.13	-11.61
Cash	21.07	20.27	-3.78
Capex	-4.89	-4.60	6.02
Free Cash Flow	-6.51	-5.68	12.76
Revenue	1.67	1.60	-4.25
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	5.13	4.58	-10.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1780.25	-279.72	-84.29
Naive Interpretation	Member

06 - Financial Health · Bad

Rating